News
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships Seeking Alpha
View ArticleMedImmune begins shipping influenza vaccine
MedImmune begins shipping influenza vaccine Yahoo/AP
View ArticleMedImmune sues Abbott over drug development deal
MedImmune sues Abbott over drug development deal Bizjournals.com
View ArticleMedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer Yahoo
View ArticleWas MedImmune worth $15.6 billion?
Was MedImmune worth $15.6 billion? Washington Post, DC
View ArticleAstraZeneca's MedImmune in China joint venture to develop inflammatory...
AstraZeneca's MedImmune in China joint venture to develop inflammatory disease drug Yahoo/AP
View ArticleChina Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture
China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture Seeking Alpha
View ArticleMedImmune partners on trials for a new slate of cancer immunotherapy combos
MedImmune partners on trials for a new slate of cancer immunotherapy combos Fierce Biotech
View ArticleAstraZeneca's MedImmune unit acquires AlphaCore Pharma
AstraZeneca's MedImmune unit acquires AlphaCore Pharma Yahoo/Fly on the Wall
View ArticleMedImmune chief taps top prospects, hunts new biologics deals
MedImmune chief taps top prospects, hunts new biologics deals Fierce Biotech
View ArticleAstraZeneca forges $500M cancer-combo tech buyout for MedImmune
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune Fierce Biotech
View ArticleAstraZeneca to Pay Up to $440 Million for Spirogen
AstraZeneca to Pay Up to $440 Million for Spirogen Bloomberg
View Article